Skip to content

The Influence of Soy Isoflavnoids on the Hypocholesterolemic Effects of Soy

The Influence of Soy Isoflavnoids on the Hypocholesterolemic Effects of Soy

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00877825
Enrollment
Unknown
Registered
2009-04-08
Start date
Unknown
Completion date
2000-04-30
Last updated
2009-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Hyperlipidemia

Keywords

Diet Therapy

Brief summary

Isoflavonoids, through their estrogen-like activity, are in part responsible for the cholesterol lowering properties of soy foods. If this is found to be so, then it would be advantageous not only to promote soy consumption, but also to identify and use soy cultivars with high isoflavonoid content in production of soy food products. These foods may have a use in the reduction of serum cholesterol and if they effectively increase the phytoestrogen activity of soy, may have a role in the prevention of other hormone dependent diseases (e.g. osteoporosis, certain cancers) in the same way as natural estrogens.

Interventions

PROCEDUREdairy food control diet and high- and low- isoflavone soyfood diets

Sponsors

University of Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* men and post-menopausal women * LDL-C \> 4.1mmol/L at recruitment * living within a 40 km radius of St. Michael's Hospital

Exclusion criteria

* lipid lowering medications * clinical or biochemical evidence of diabetes, renal or hepatic disease * body mass index (BMI) \>38 kg/m2 * antibiotic use within the last three months * hormone replacement therapy * smoking or significant alcohol use (\>1 drink/d) * triglyceride level \> 4.0mmol/L

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026